My name is Julie Tucker. Since late 2015, I have spent the one day a week when I’m not managing the newborn hearing screening service in Oxford writing the new NHS Newborn Hearing Screening Programme (NHSP) operational guidance on behalf of …
screening benefits and risks
In his latest PHE Screening blog post written for his fellow GPs, Dr Jim McMorran looks at primary care issues relating to sickle cell and thalassaemia (SCT) screening.
Today we published the abdominal aortic aneurysm (AAA) screening, surveillance and outcome data for the 2015 to 2016 screening year (1 April 2015 to 31 March 2016).
The NHS Sickle Cell and Thalassaemia (SCT) Programme endorses short counselling courses for health professionals who care for families affected by the 2 conditions.
PHE screening team members and clinicians attended the 40th European Congress of Cytology in Liverpool.
We get lots of questions about how to apply duty of candour regulations in screening programmes.
We’ve often discussed on this blog why screening is always a choice. This means that while many people will want to be screened, some won’t. It is our job to make sure the choice someone makes is the right one for them and acted on appropriately.